Amyris, Inc. (NASDAQ:AMRS) specialty chemical provider, is reporting third quarter earnings results on Thursday 5th November 2020, before market open.
The consensus estimates from Thomson Reuters are loss of $ 0.17 per share.
For the full year, analysts predict revenues of $ 183.74 million, while looking forward to loss of $ 1.23 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 220.32 million ~ $ 220.32 million
Click Here For More Historical Outlooks Of Amyris, Inc.
Previous Quarter Performance
Amyris, Inc. announced loss for the second quarter of $ 0.32 per share, from the revenue of $ 30.00 million. The consensus estimates are loss of $ 0.19 per share from $ 35.76 million in revenue. The bottom line results missed street analysts by $ 0.13 or 68.42 percent, at the same time, top line results fell short of analysts by $ 5.76 million or 16.11 percent.
Stock Performance
Shares of Amyris, Inc. traded low $ -0.07 or -2.59 percent on Wednesday, reaching $ 2.63 with volume of 2.11 million shares. Amyris, Inc. has traded high as $ 2.81 and has cracked $ 2.57 on the downward trend
The closing price of $ 2.63, representing a 92.86 % increase from the 52 week low of $ 1.40 and a 55.52 % decrease over the 52 week high of $ 6.07.
The company has a market capital of $ 538.44 million and is part of the Basic Materials sector and Specialty Chemicals industry.
Conference Call
Amyris, Inc. will be hosting a conference call at 9:00 AM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.amyris.com
Amyris, Inc., an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products. The company delivers its No Compromise products and services in markets, such as specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals.
